Health

The FDA approved Rasonque (daraxonrasib), the first targeted…

The FDA approved Rasonque (daraxonrasib), the first targeted RAS inhibitor for metastatic pancreatic cancer Pancreatic adenocarcinoma is usually found late and has had few options. A first-in-class drug that more than doubled median survival in that…